Cryo-Cell International Past Earnings Performance
Past criteria checks 0/6
Cryo-Cell International's earnings have been declining at an average annual rate of -37.2%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 0.7% per year.
Key information
-37.2%
Earnings growth rate
-37.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -0.7% |
| Return on equity | n/a |
| Net Margin | -31.0% |
| Last Earnings Update | 29 Feb 2024 |
Revenue & Expenses BreakdownBeta
How Cryo-Cell International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 31 | -10 | 18 | 2 |
| 30 Nov 23 | 31 | -10 | 17 | 1 |
| 31 Aug 23 | 31 | 3 | 16 | 1 |
| 31 May 23 | 31 | 2 | 16 | 1 |
| 28 Feb 23 | 31 | 3 | 16 | 0 |
| 30 Nov 22 | 30 | 3 | 16 | 0 |
| 31 Aug 22 | 30 | 1 | 15 | 0 |
| 31 May 22 | 30 | 2 | 15 | 0 |
| 28 Feb 22 | 29 | 2 | 15 | 0 |
| 30 Nov 21 | 29 | 2 | 15 | 0 |
| 31 Aug 21 | 29 | 4 | 14 | 0 |
| 31 May 21 | 30 | 4 | 13 | 0 |
| 28 Feb 21 | 30 | 4 | 14 | 0 |
| 30 Nov 20 | 31 | 4 | 14 | 0 |
| 31 Aug 20 | 32 | 3 | 15 | 0 |
| 31 May 20 | 32 | 4 | 15 | 0 |
| 29 Feb 20 | 32 | 3 | 15 | 0 |
| 30 Nov 19 | 32 | 2 | 15 | 0 |
| 31 Aug 19 | 32 | 2 | 15 | 0 |
| 31 May 19 | 32 | 1 | 15 | 0 |
| 28 Feb 19 | 30 | 2 | 15 | 0 |
| 30 Nov 18 | 29 | -1 | 15 | 0 |
| 31 Aug 18 | 27 | -1 | 14 | 0 |
| 31 May 18 | 26 | -1 | 14 | 0 |
| 28 Feb 18 | 26 | -1 | 14 | 0 |
| 30 Nov 17 | 25 | 2 | 13 | 0 |
| 31 Aug 17 | 25 | 2 | 14 | 0 |
| 31 May 17 | 24 | -1 | 14 | 0 |
| 28 Feb 17 | 24 | -1 | 14 | 0 |
| 30 Nov 16 | 23 | -1 | 15 | 0 |
| 31 Aug 16 | 23 | -2 | 15 | 0 |
| 31 May 16 | 22 | 8 | 13 | 0 |
| 29 Feb 16 | 21 | 8 | 13 | 0 |
| 30 Nov 15 | 21 | 8 | 12 | 0 |
| 31 Aug 15 | 20 | 8 | 12 | 0 |
| 31 May 15 | 20 | 0 | 12 | 0 |
| 28 Feb 15 | 20 | 0 | 12 | 0 |
| 30 Nov 14 | 20 | 1 | 12 | 0 |
| 31 Aug 14 | 20 | 1 | 12 | 0 |
| 31 May 14 | 20 | 1 | 12 | 0 |
| 28 Feb 14 | 20 | 0 | 12 | 0 |
| 30 Nov 13 | 19 | 0 | 11 | 0 |
| 31 Aug 13 | 19 | -1 | 12 | 0 |
| 31 May 13 | 19 | -1 | 13 | 0 |
Quality Earnings: CCEL is currently unprofitable.
Growing Profit Margin: CCEL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CCEL is unprofitable, and losses have increased over the past 5 years at a rate of 37.2% per year.
Accelerating Growth: Unable to compare CCEL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CCEL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).
Return on Equity
High ROE: CCEL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.